Study Milestone definition

Study Milestone means the enrollment of a patient in a Phase II study related to the AEVI-002 Program, the AEVI-006 Program or the AEVI-007 Program, prior to the twenty-four (24)-month anniversary of the date of this Agreement.
Sample 1Sample 2Sample 3
Study Milestone the date for delivery of one or more Deliverables, as set out in the Technical Specification and Schedule of Study;
Sample 1Sample 2

Examples of Study Milestone in a sentence

  • On the other hand, a larger emphasis on solar generating capacity, especially with heat and coldness storage could be combined with lower efficiency targets.

  • Meeting of a Study Milestone or supply of a Deliverable occurs whenever the Contractor has completed all of the Works which the Contractor has undertaken to perform according to the Annex B: Technical Specification and Schedule of Study by the relevant Study Milestone.

  • However, these systems are not feasible currently because the tariffs are too large for the small amounts of Bangla-­‐Pesa used for each transaction.

  • The Contractor shall not commence provision of the Study until Study Start Date, as identified in accordance with Annex C: Schedule of Study and shall ensure that the Deliverables are furnished to the Principal on or before each relevant Study Milestone.

  • The only way the migration can be stopped is by providing opportunities in far flung areas with equal earning power, and making the companies to access these remote places instead of concentrating on colleges in the mega cities for their manpower requirements.

  • Review pre-requisites, content, and success criteria are documented in NPR 7123.1. 1.3 Study Milestone ScheduleThe Contractor shall execute the study in accordance with the following milestone schedule.

  • The Provisional Completion Note shall include the Deliverable and adequate supporting Documentation and information relevant to the Study Milestone attained and/or Deliverable completed.

  • Figure 1-1Schedule of Key D.C. Process Dates for the City of Stratford Schedule of Study Milestone 1.3 Changes to the D.C.A.: Bill 73 – Smart Growth for our Communities Act, 2015‌ With the amendment of the D.C.A. (as a result of Bill 73 and O.

  • Figure 1-1Schedule of Key D.C. Process Dates for the Municipality of Thames Centre Schedule of Study Milestone 1.3 Changes to the D.C.A.: Bill 73 – Smart Growth for our Communities Act, 2015‌ With the amendment of the D.C.A. (as a result of Bill 73 and O.

  • On meeting a Study Milestone and/or producing a Deliverable (including all Documentation forming part of the Deliverable) constituting all or an identifiable part of the Study, the Contractor shall issue to the Principal a Provisional Completion Certificate substantially in the form of Annex F (Form of Provisional Completion Certificate) (hereinafter, the “Provisional Completion Certificate”).

Related to Study Milestone

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Development Milestone Event shall have the meaning set forth in Section 9.2(a).

  • Milestone means an event or task described in the Implementation Plan which must be completed by the corresponding date set out in such plan;

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Milestone Event has the meaning set forth in Section 8.4.

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Sales Milestone Payment shall have the meaning set forth in Section 8.4.

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Milestone Events has the meaning set forth in Section 3.3 (Milestone Payments).

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Milestone Payment means a payment identified in the Implementation Plan to be made following the issue of a Satisfaction Certificate in respect of Achievement of the relevant Milestone;

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Milestone Payments has the meaning set forth in Section 4.2.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.